A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
| 対象疾患 | Cardiovascular Disorder, Coronary Artery Disease, Diabetes Mellitus, Obesity-Related Malignant Neoplasm |
|---|---|
| 相 | 該当なし |
| スポンサー | Roswell Park Cancer Institute |
| ステータス | 完了 |
| 参加者数 | 48 名 |
| 介入（薬剤） | Education Intervention, Observation of Indigenous SIPin Interventon, Discussion |
| 開始日 | 2022年7月20日 |
| 完了日 | 2025年9月15日 |
| 結果公開日 | 2026年7月28日 |
概要
This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletics communities. Sugary drinks are drinks like pop, soda, and juice. Increased sugar consumption may lead to an increased risk of chronic diseases, including obesity, diabetes, some types of obesity-related cancers, coronary heart disease, hypertension, and dental decay. A culturally sensitive program may help reduce sugar-sweetened beverage consumption in Native American men
Change in SSB Intake for Men Affiliated With Native American Athletic Communities
| Arm 1 - Indigenous SIPin | 0.18 ± 87.31 kcal per day |
|---|
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- Ignite Pilot: Goal Setting in a Digital Weight Loss Intervention — Stanford University
- Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects — University of Pennsylvania
- Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes — The Cleveland Clinic
- Time Restricted Eating for Weight Loss Maintenance — NYU Langone Health
- Diabetes Prevention Program Outcomes Study — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Effect of PDE5 Inhibition on Adipose Metabolism in Humans — Vanderbilt University Medical Center